SCHEMBL6510822

SCHEMBL6510822

CC[C@H](C)[C@H](N)C(=O)NS(=O)(=O)N1CN([C@@H]2O[C@H](CO)C(O)C2O)c2ncnc(N)c21

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IARS1 P41252 7/20 0.51
TARS1 P26639 2/20 0.42
HIF1A Q16665 1/20 0.38
HSPA8 P11142 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7110520 0.79 SARS1 (0.43) HSPA8
SCHEMBL846742 0.74 HSPA8 (0.46) HIF1AHSPA8
SCHEMBL7104843 0.74 DOT1L (0.40)
SCHEMBL177666 0.73 HSPA8 (0.44) HIF1AHSPA8
SCHEMBL1976100 0.73 HSPA8 (0.46) HIF1AHSPA8
SCHEMBL830796 0.72 MAPK1 (0.50) HIF1AHSPA8
SCHEMBL830795 0.72 MAPK1 (0.50) HIF1AHSPA8
SCHEMBL2197504 0.72 CDK1 (0.48) HIF1AHSPA8
SCHEMBL724943 0.70 MAPK1 (0.50) HIF1AHSPA8
SCHEMBL1936249 0.70 ADK (0.50) HIF1AHSPA8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050181464-A1 Novel purified polypeptides from bacteria AFFINIUM PHARMACEUTICALS, INC. (CA) 2005-08-18 US disclosed
WO-2003102190-A2 BACTERIAL POLYPEPTIDES INVOLVED IN VIABILITY AFFINIUM PHARMACEUTICALS, INC. (CA) 2003-12-11 WO disclosed